Clinical Trial Update: An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

View source ↗

Summary

An observational study evaluating the efficacy and safety of the Avelumab + Axitinib combination in participants with advanced renal cell carcinoma has been com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Axitinib (Axitinib)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Carcinoma, Renal Cell | Status: COMPLETED | Results posted: 2025-11-28